Precision medicine by targeting PD-L1 variants for treatment of cancer
US9045545B1 · kind B1 · utility
33Cited by
59References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 7, 2014 |
| Grant date | Jun 2, 2015 |
| Priority date | — |
| Expiry date | Nov 7, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.